The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: FTSE Boosted By US Stimulus Hopes; Rolls Slides

Mon, 08th Feb 2021 08:41

(Alliance News) - London's FTSE 100 was higher in early trade on Monday, shrugging off share price falls for AstraZeneca, Rolls-Royce and Experian, as global markets got a boost from progress on US President Joe Biden's USD1.9 trillion stimulus plan.

The FTSE 100 index was up 18.62 points, or 0.3%, at 6,507.95. The mid-cap FTSE 250 index was down 41.65 points, or 0.2%, at 21,025.22. The AIM All-Share index was down 0.3% at 1,208.35.

The Cboe UK 100 index was up 0.3% at 647.13 points. The Cboe 250 was down 0.1% at 18,479.51, and the Cboe Small Companies was up 1.3% at 12,629.96.

In mainland Europe, the CAC 40 in Paris was up 0.3% while the DAX 30 in Frankfurt was 0.5% higher.

Sterling was trading at USD1.3727 on Monday morning, largely flat from USD1.3728 at the London equities close on Friday.

The euro stood at USD1.2042 on Monday morning London time, up from USD1.2025 at the European equities close on Friday.

Rolls-Royce was the worst-performing FTSE 100 stock, down 2.2%. It is planning to shut down its jet engine factories this summer due to insufficient work, the Telegraph reported on Saturday.

According to the newspaper, this is the first time Roll-Royce has done this and results from what Rolls-Royce described as a "significantly reduced" workload resulting from the Covid-19 pandemic.

The two-week closures, focused around its headquarters in Derby, will affect all of the 19,000 staff within Rolls-Royce's civil aerospace division, including 12,500 UK staff, who make airliner jet engines.

Experian fell 1.4%. It said it is continuing a "detailed forensic investigation" following a Brazilian data leak, but noted that evidence suggests its technology systems have not been compromised.

The credit checking firm noted that "data which is being illegally offered for sale on the internet, some of which may have been sourced from Serasa's non-sensitive marketing data". Serasa is a Brazilian unit owned by Experian. Like its parent, Serasa provides credit granting and validation services.

Experian said it is "continuing to carry out a detailed forensic investigation".

So far, the company explained, it knows that data offered includes photographs, social media logins, vehicles registrations, and "social security INSS", the latter concerning social security contributions in Brazil. Experian however, noted that this data is not collected by Serasa.

AstraZeneca was 0.1% lower, after South Africa temporarily suspended the AstraZeneca and Oxford University jab against a new Covid-19 variant found in the country, according to the health department and top local scientists.

The AstraZeneca-Oxford vaccine protects against the original Covid-19 strain, but its efficacy drops off substantially when it comes to the new variant called B.1.351 or 501.V2, raising serious concerns, said Shabir Madhi, the professor of vaccinology at the University of the Witwatersrand, citing a new local study involving 2,000 participants.

BDSwiss Head of Investment Research Marshall Gittler commented: "The disappointing results could raise doubts about how quickly the world will return to normal."

Paddy Power owner Flutter Entertainment rose 2.1%. Morgan Stanley raised the stock to Overweight from Equal-Weight.

Lloyds Banking also climbed 2.1% after Goldman Sachs lifted the lender to Neutral from Sell.

Benefiting as well from a ratings lift was mid-cap mining technology company Weir Group, up 4.3%. It was the best FTSE 250 performer early on Monday after Morgan Stanley raised the stock to Overweight from Equal-Weight.

Share price falls for pub owners JD Wetherspoon, down 3.5%, and Mitchells & Butlers, 2.0% lower, weighed on the mid-cap index.

The Daily Telegraph over the weekend reported the prospect of dry pubs was being discussed as an option to allow bars to open their doors in April but UK government sources were dismissive about the idea, asking what the point of a pub without alcohol would be.

British Beer & Pub Association Chief Executive Emma McClarkin said: "Opening pubs without selling alcohol is not 'reopening' pubs at all."

Online retailer boohoo Group fell 2.9%. It joined online peer ASOS in snapping up retail brands from the failed Arcadia Group.

boohoo will buy the e-commerce and digital assets and associated intellectual property rights of Burton, Dorothy Perkins and Wallis for GBP25.2 million from Arcadia's joint-administrators.

"This is a great acquisition for the group as we extend our market share across a broader demographic, capitalising on growth opportunities as more and more customers shop online. We continue to grow our portfolio of brands and customer base, strengthening our position as a leader in global fashion e-commerce," boohoo Executive Chair Mahmud Kamani said.

The deal does not include any stores, however.

Arrow Global Group shares shot up 28% early on Monday. TDR Capital said it made another approach to acquire the buyer of debt from banks, credit card companies and telecommunications businesses.

TDR said the latest proposal, made on Friday, prices Arrow Global shares at 305 pence, which the private equity firm said was a 36% premium to the company's 224.0p closing price on Thursday.

A 305p offer would value all of Arrow Global at roughly GBP540 million.

On Monday, Arrow Global shares were trading at 294.00p, valuing the firm at around GBP525.0 million.

TDR added that it previously made approaches at 250p per share, 265p and 290p. The most recent was shrugged off by the Arrow board in late-January.

This time, Arrow's Group Chief Investment Officer Zachary Lewy "has entered into a binding letter of support", TDR said. The private equity firm noted "he is fully supportive of the fourth proposal".

Against the yen, the dollar was trading at JPY105.53, improved from JPY105.45 at the London market close on Friday.

"The prospect of additional fiscal stimulus also continues to buoy markets. Late on Friday, the US House of Representatives gave final approval to a budget approval that would allow President Biden's USD1.9 trillion stimulus plan to be fast tracked. Over the weekend, US Treasury Secretary, Janet Yellen touted the relief package as having the potential to return the US to full employment in 2022," analysts at Lloyds said.

US futures were higher on Monday. The Dow Jones Industrial Average and S&P 500 were both called up 0.3% and the Nasdaq Composite up 0.5%.

By Eric Cunha; ericcunha@alliancenews.com;

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.